Lexicon Pharmaceuticals (LXRX) Debt to Equity: 2009-2012
Historic Debt to Equity for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $0.09.
- Lexicon Pharmaceuticals' Debt to Equity fell 36.70% to $0.09 in Q3 2012 from the same period last year, while for Sep 2012 it was $0.09, marking a year-over-year decrease of 36.70%. This contributed to the annual value of $0.08 for FY2011, which is 170.31% up from last year.
- Latest data reveals that Lexicon Pharmaceuticals reported Debt to Equity of $0.09 as of Q3 2012, which was down 4.56% from $0.10 recorded in Q2 2012.
- Over the past 5 years, Lexicon Pharmaceuticals' Debt to Equity peaked at $0.15 during Q3 2011, and registered a low of $0.03 during Q1 2011.
- For the 3-year period, Lexicon Pharmaceuticals' Debt to Equity averaged around $0.09, with its median value being $0.09 (2012).
- In the last 5 years, Lexicon Pharmaceuticals' Debt to Equity tumbled by 68.65% in 2010 and then skyrocketed by 376.04% in 2011.
- Lexicon Pharmaceuticals' Debt to Equity (Quarterly) stood at $0.09 in 2009, then rose by 26.36% to $0.12 in 2010, then dropped by 27.45% to $0.08 in 2011, then tumbled by 36.70% to $0.09 in 2012.
- Its Debt to Equity stands at $0.09 for Q3 2012, versus $0.10 for Q2 2012 and $0.09 for Q1 2012.